Neurology and Neurosurgery - Global Neurology Academy

81-96 of 498

Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
NeuroFrontiers
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
The Role of Neurofilament Light Chain in MS Management
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiers
The Role of Neurofilament Light Chain in MS Management
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiers
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS; Michael Halassa, MD, PhD
- Alexandria May, PharmD, BCPS
- Michael Halassa, MD, PhD
How Muscarinic Therapies Are Redefining Schizophrenia Care
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiers
How Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
- Michael Halassa, MD, PhD
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiers
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Jerome Lisk, MD, MBA, M.S., FAAN; Michael Salvatore, PhD
- Jerome Lisk, MD, MBA, M.S., FAAN
- Michael Salvatore, PhD
- Vicki Nejtek-Salvatore, PhD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiers
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP; Stephen Marder, MD
- Ashley Baker, MSN, PMHNP
- Stephen Marder, MD
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP; Hannah Brown, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Brown, MD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
- Jeffrey A. Lieberman, MD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Charles Turck, PharmD, BCPS, BCCCP; Tushita Mayanil, MBBS (MD)
- Charles Turck, PharmD, BCPS, BCCCP
- Tushita Mayanil, MBBS (MD)
- Melanie Yabs, PharmD, MS, BCPP
Digital Danger: Understanding AI Psychosis in Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Identifying and Managing Violence Risk in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of Schizophrenia
Identifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
CME/CE
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
CME/CE
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
CME/CE
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
On the Frontlines of Migraine
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Ashley Baker, MSN, PMHNP; Chia-Chun Chiang, MD
- Ashley Baker, MSN, PMHNP
- Chia-Chun Chiang, MD
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
CME/CE
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO; Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
1.00 credit
- Emily D. Clark, DO
- Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
- Susan Scanland, MSN, CRNP, GNP-BC, CDP
- Anthony J. Viera, MD, MPH
1.00 credit

Previous
1
2
…
4
5
6
7
8
…
31
32
Next

6/11